<DOC>
	<DOCNO>NCT00905177</DOCNO>
	<brief_summary>The goal research study develop well dose anticoagulation medication Caucasian African Americans analysis various genetic factor .</brief_summary>
	<brief_title>Predictors Anticoagulation Control Warfarin Therapy</brief_title>
	<detailed_description>This prospective cohort study among adult patient require warfarin therapy . Patients present anticoagulation identify start therapy follow throughout course reach maintenance dose . We develop dose equation warfarin use patient , environmental genetic factor .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>All Caucasians African Americans new warfarin therapy Under 21 year age Non caucasian Non african american Have abnormal INR warfarin heparin therapy Unable provide consent</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>deep vein thrombosis</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>warfarin</keyword>
	<keyword>coumadin</keyword>
</DOC>